99 related articles for article (PubMed ID: 8306457)
1. Abnormally fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease.
Chambers W; Thompson S; Skillen AW; Record CO; Turner GA
Clin Chim Acta; 1993 Oct; 219(1-2):177-82. PubMed ID: 8306457
[No Abstract] [Full Text] [Related]
2. Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report.
Thompson S; Matta KL; Turner GA
Clin Chim Acta; 1991 Sep; 201(1-2):59-64. PubMed ID: 1790626
[No Abstract] [Full Text] [Related]
3. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease.
Mann AC; Record CO; Self CH; Turner GA
Clin Chim Acta; 1994 Jun; 227(1-2):69-78. PubMed ID: 7955423
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
Thompson S; Turner GA
Br J Cancer; 1987 Nov; 56(5):605-10. PubMed ID: 3426924
[TBL] [Abstract][Full Text] [Related]
5. Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis.
Thompson S; Cantwell BM; Cornell C; Turner GA
Br J Cancer; 1991 Aug; 64(2):386-90. PubMed ID: 1892771
[TBL] [Abstract][Full Text] [Related]
6. Serum sialic acid as a marker of alcohol consumption: effect of liver disease and heavy drinking.
Romppanen J; Punnonen K; Anttila P; Jakobsson T; Blake J; Niemelä O
Alcohol Clin Exp Res; 2002 Aug; 26(8):1234-8. PubMed ID: 12198399
[TBL] [Abstract][Full Text] [Related]
7. Serum ethanol estimations in the control of alcohol abstinence in patients with liver disease.
Staun-Olsen P; Thomsen AC
Scand J Gastroenterol; 1979; 14(7):785-9. PubMed ID: 538408
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone changes in chronic liver disease: a matched study of alcoholic versus non-alcoholic liver disease.
Bannister P; Oakes J; Sheridan P; Losowsky MS
Q J Med; 1987 Apr; 63(240):305-13. PubMed ID: 2960998
[TBL] [Abstract][Full Text] [Related]
9. Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?
Schöniger-Hekele M; Ramskogler K; Hartl D; Lesch OM; Müller C
Wien Med Wochenschr; 2006 Apr; 156(7-8):216-22. PubMed ID: 16823539
[TBL] [Abstract][Full Text] [Related]
10. [Carbohydrate-deficient transferrin. A new, highly specific marker for chronic alcohol consumption].
Seitz G; Stickel F; Fiehn W; Werle E; Simanowski UA; Seitz HK
Dtsch Med Wochenschr; 1995 Mar; 120(12):391-5. PubMed ID: 7705200
[TBL] [Abstract][Full Text] [Related]
11. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic characteristics of different carbohydrate-deficient transferrin methods in the detection of problem drinking: effects of liver disease and alcohol consumption.
Anttila P; Järvi K; Latvala J; Blake JE; Niemelä O
Alcohol Alcohol; 2003; 38(5):415-20. PubMed ID: 12915516
[TBL] [Abstract][Full Text] [Related]
13. Vulnerability to alcoholic liver disease.
Arria AM; Tarter RE; Van Thiel DH
Recent Dev Alcohol; 1991; 9():185-204. PubMed ID: 1758983
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19.
Gonzalez-Quintela A; García J; Campos J; Perez LF; Alende MR; Otero E; Abdulkader I; Tomé S
Alcohol; 2006 Jan; 38(1):45-9. PubMed ID: 16762691
[TBL] [Abstract][Full Text] [Related]
15. The glycosylation of haptoglobin in rheumatoid arthritis.
Thompson S; Dargan E; Griffiths ID; Kelly CA; Turner GA
Clin Chim Acta; 1993 Oct; 220(1):107-14. PubMed ID: 8287554
[No Abstract] [Full Text] [Related]
16. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men.
Harada S; Takebayashi T; Kurihara A; Akiyama M; Suzuki A; Hatakeyama Y; Sugiyama D; Kuwabara K; Takeuchi A; Okamura T; Nishiwaki Y; Tanaka T; Hirayama A; Sugimoto M; Soga T; Tomita M
Environ Health Prev Med; 2016 Jan; 21(1):18-26. PubMed ID: 26459263
[TBL] [Abstract][Full Text] [Related]
17. [Complex study of glycoproteins in liver disease].
Pateva R; Koichev K; Vurbanov G; Rusinov E; Danev I
Vutr Boles; 1982; 21(2):65-9. PubMed ID: 7101892
[TBL] [Abstract][Full Text] [Related]
18. Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.
Rua RM; Ojeda ML; Nogales F; Rubio JM; Romero-Gómez M; Funuyet J; Murillo ML; Carreras O
Life Sci; 2014 Jan; 94(2):158-63. PubMed ID: 24157457
[TBL] [Abstract][Full Text] [Related]
19. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
20. The hepatic component in alcoholic encephalopathy.
Banciu T; Weidenfeld H; Wilham V; Berinde L; David P; Sgăvirdea C; Ocica I
Med Interne; 1982; 20(1):67-71. PubMed ID: 7123107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
